Students may earn the Doctor of Pharmacy (Pharm.D.) en route to the M.S. in Pharmaceutical Sciences with a concentration in either Pharmacoeconomics, Epidemiology, Pharmaceutical Policy and Outcomes Research or in Toxicology and Pharmaceutical Sciences. See the Graduate and Professional Dual Degree section of this Catalog.
Applications to the Pharmaceutical Sciences Graduate Program use the Graduate Studies Admissions online application. Information and instructions for completing this form are available at the Graduate Studies Web site. Application materials for international students can be found through The University of New Mexico’s Global Education Office.
Students wishing to pursue a graduate degree in Pharmaceutical Sciences must meet the general requirements for graduate admission found in the Graduate Program section of this Catalog. In addition, each concentration of study has prerequisites for admission that are described below.
The Committee on Studies determines the Programs of Study for graduate students for each concentration. In general, this program consists of core and elective course work required of all students. However, in some cases, the Committee on Studies may approve a Program of Study that takes advantage of previously completed coursework or provides interdisciplinary training of interest to particular students. More specific information on the programs is given below.
The Pharmacoeconomics, Epidemiology, Pharmaceutical Policy and Outcomes Research (PEPPOR) concentration is a program of study and research leading to the M.S. and/or Ph.D. degree emphasizing the social, psychosocial, political, legal, historical and economic factors that impact on the use, non-use and misuse of drugs. It emphasizes human behavior in health illness, cultural determinants, health service systems organization, finance and economics. Individuals examine the societal systems in which patients, pharmacists and other healthcare practitioners interact, behave, perform, generate revenues, provide services and are educated. They generate knowledge about man as a social, cultural, psychological and biological being, as well as the intervention and effect of health care systems upon man and the economics of pharmacy services. Study and research training in this discipline prepares individuals with the background and problem-solving skills to evaluate and design systems for the delivery of pharmaceutical systems and to apply behavioral and social interdisciplinary theories to the study of pharmacy practice. Two emphases areas are available:
An individual program of coursework is determined for each student according to his/her career goals by a Committee on Studies. General requirements for graduate admission to and completion of the degree are specified the Graduate Program section of this Catalog. For admission information and more information on the curriculum, visit the College of Pharmacy Web site.
A program leading to the M.S. in Pharmaceutical Sciences with a concentration in Radiopharmacy is offered either on campus or online to individuals who have received a professional degree in pharmacy or a B.S. in a health-related science. The primary mission of the Radiopharmacy Education Program is to provide a comprehensive training experience that affords individuals the opportunity to acquire the scientific knowledge, technical skills, and professional judgment required to promote patient care through assurance of the safe and efficacious use of radiopharmaceuticals and ancillary medications for diagnosis and therapy. In order to best accomplish this mission, it is necessary to develop professionals who can solve problems, think logically and work independently or in collaboration to conduct research that adds to the knowledge base in nuclear medicine and radiopharmaceutical science.
Moreover, nuclear pharmacy is practiced in countries all around the world. Not only are U.S. pharmacists traveling to these countries to meet their health care needs, but pharmacists from these countries are also seeking opportunities to become competently trained nuclear pharmacy practitioners in order to return to their native lands. To maintain its reputation as a premier nuclear pharmacy education program, The University of New Mexico College of Pharmacy must seek to address the idiosyncrasies and needs of nuclear pharmacy on an international scale.
The comprehensive nature of the program is related to the fact that information is made available in a variety of ways. The program, therefore, is able to achieve the following goals:
The entire pharmacy profession, including the specialty of nuclear pharmacy, is an applied science. However, nuclear pharmacy, even more so than general pharmacy practice, relies upon a firm grounding in multiple basic sciences. To practice nuclear pharmacy, you must be able to extemporaneously compound and test a wide range of radioactive medications, develop and enforce adequate radiation protection measures for one’s self and coworkers, meet the demand of numerous regulators and troubleshoot a variety of imaging pitfalls and artifacts and also provide patient care in a setting that is foreign to most pharmacists. Therefore, to achieve an optimal learning environment for nuclear pharmacy, it is essential to have an appropriate blending of the clinical sciences with multiple basic sciences.
College-level organic chemistry, physics and mathematics through calculus are prerequisites for entry into the program. Didactic and laboratory coursework, research leading to a Plan I (thesis) or Plan II (non-thesis) degree and an opportunity for experience in radiopharmacy practice are components of the program.
General requirements for graduate admission to and completion of the degree are specified the Graduate Program section of this Catalog. The student’s program is developed and supervised by a Committee on Studies. Requirements for this degree can be completed entirely online.
The M.S. in Pharmaceutical Sciences with a concentration in Toxicology and Pharmaceutical Sciences encompasses a broad range of scientific disciplines that are critical to the discovery and development of new drugs and therapies, including drug design and chemical biology, pharmaceutics and drug delivery, radiopharmaceutical target imaging, and pharmacokinetics, pharmacodynamics, drug metabolism, pharmacogenomics, and toxicology. The group is focused on developing outstanding scientists through training in the biomedical and pharmaceutical sciences and disease processes. Specific strengths of the program include gene-environment interactions and the mechanisms by which exposure to environmental hazards adversely affect living organisms. Highly innovative programs such as the New Mexico Center for Environmental Health Sciences, the New Mexico Center for Isotopes in Medicine, the UNM Biomedical Research and Integrative Imaging (BRaIN) Center offer excellent opportunities for collaborative basic and translational research among faculty in the College of Pharmacy, School of Medicine, and Lovelace Respiratory Research Institute.
These programs are designed to develop outstanding M.S. and Ph.D. research scientists by providing a firm foundation of knowledge in biomedical sciences augmented by an emphasis on research-based, experimental approaches to learning. Areas of research are diverse and current research interests can be found on the program’s Web site. Typically, students graduating from this program have gone on to careers in academia, the pharmaceutical industry, government regulatory agencies, and biotechnology firms.
The M.S. in Pharmaceutical Sciences concentration in Toxicology and Pharmaceutical Sciences is available under both Plan I (thesis) and Plan II (non-thesis) in accordance with the regulations found in the Graduate Program section of this Catalog.
Courses
PHRM 105.
Introduction to Pharmacy Practice and Pharmaceutical Sciences.
(3)
The course provides an introduction to the scientific principles that form the basis for pharmacy practice and an overview of contemporary pharmacy practice, including specialized patient care settings.
PHRM 301.
Applied Biochemistry.
(3)
The course covers basic principles of protein, carbohydrate and lipid function, metabolism, and an introduction to molecular mechanisms of drug action.
Prerequisite: CHEM **302.
PHRM 302.
Physical Pharmacy and Biopharmaceutics.
(3)
This course provides an introduction to physical pharmacy and biopharmaceutical principles that impact drug development and the performance of pharmaceutical dosage forms.
Prerequisite: PHRM 301 and 305.
PHRM 305.
Fundamentals of Pathophysiology and Immunology.
(3)
The course provides in introduction to the fundamentals of human pathophysiology and diagnostic tests used to evaluate normal and abnormal biomarkers and the underlying principles of human immunology.
Prerequisite: BIOL 2225.
PHRM 310.
Fundamentals of Pharmacokinetics and Dosage Forms.
(3)
An introduction to the influence of absorption, distribution, metabolism, and excretion on the time course of drug levels in body as well as fundamental principles in the design and manufacture of dosage forms.
Prerequisite: 301; Pre- or corequisite 302.
PHRM 311.
Introduction to Pharmacology and Medicinal Chemistry.
(4)
This course will provide an introduction to pharmacology, drug metabolism, toxicology, and elimination of drugs that act upon the autonomic nervous system.
Prerequisite: BIOL 2225.
PHRM 315.
Pharmaceutical Sciences Laboratory Techniques.
(3)
The course provides an introduction to common laboratory techniques essential in a pharmaceutical sciences laboratory setting.
Pre- or corequisite: PHRM 302, 310 and 311.
PHRM 424.
Dosage Forms.
(3)
To provide students with an introduction to the fundamental principles of dosage forms, their design and the processes used in manufacturing and compounding drug products.
Prerequisite: 302 and 310.
PHRM 435.
Quality Control and Regulatory Affairs.
(3)
To provide students with an introduction to quality control and regulatory affairs associated with drug product development.
Prerequisite: 302 and 310 and 311.
PHRM 476 / 576.
Molecular and Cellular Pharmacology.
(3)
An overview of principles and basis of modern molecular and cellular pharmacology.
{Spring}
PHRM 493 / 593.
Pharmaceutical Sciences and Toxicology Seminar.
(1, no limit Δ)
Research seminars on current topics in pharmaceutical sciences and toxicology will be presented by students and faculty from within UNM and from invited speakers outside of UNM.
Restriction: permission of instructor.
PHRM 496.
Topics in Pharmacy.
(1, may be repeated twice Δ)
Restriction: permission of instructor.
PHRM 497.
Problems in Pharmacy.
(1-5, no limit Δ)
Research and library problems in some phase of pharmacy. Not for professional students in the College of Pharmacy curriculum.
Restriction: permission of instructor.
PHRM 498.
Problems in Pharmacy.
(1-5, no limit Δ)
Research and library problems in some phase of pharmacy. Not for professional students in the College of Pharmacy curriculum.
Restriction: permission of instructor.
PHRM 535.
Supplementary Training in Pharmaceutical Sciences.
(1)
This course provides supplementary training to PHRM 700-level courses through analysis of the relevant scientific literature. Course will require mastery of topics in PharmD courses with a focus on aspects of drug research and development.
Prerequisite: 706 and 710 and 731.
Corequisite: 732.
Restriction: permission of instructor.
PHRM 536 / 736.
Introduction to Pharmacogenomics.
(2)
An introduction to how inherited variations in genes dictate drug response. Topics covered include basic principles of medical genetics, chemotherapy improvement through pharmacogenomics, as well as the ethical, legal, and social impact of pharmacogenomics.
PHRM 545.
Pharmacoeconomics.
(3)
The course will discuss the theories, techniques and methodologies used to design, conduct and critique pharmacoeconomic and health outcomes research studies.
PHRM 546.
Healthcare Systems Review.
(3)
An overview of the healthcare system, the pharmacy profession, and health services research. Students learn to evaluate research and develop skills in reviewing and summarizing literature regarding current and future problems in healthcare.
PHRM 547.
Research Design and Analysis.
(3)
The course will provide training in research design and statistical methods used in conjunction with various studies. It will provide students with experience in the application of epidemiological and biostatistical methods available in SAS.
Prerequisite: EDPY 511.
Corequisite: PH 502.
PHRM 548.
Ethics Clinical Trials-Informed Consent.
(2)
The study of the history, ethical versus scientific methodological conflicts, and other issues that are generated by the conduct of randomized controlled clinical trials using human beings.
PHRM 549.
Regulatory Issues in Clinical Trials.
(2)
The study of federal regulations and guidelines that govern the planning and conduct of randomized controlled clinical trials in humans with drugs and devices.
PHRM 551.
Fundamentals of Clinical Trials.
(3)
Advanced readings on topics relating to the pharmaceutical sciences in the area of the fundamental concepts and methods of designing, conducting, monitoring and closing out multicenter clinical trials.
Restriction: permission of instructor.
PHRM 570.
Multicenter Clinical Trials.
(4, may be repeated twice Δ)
The multicenter clinical trials (MCCT) experiential provides the pharmaceutical sciences graduate student applied training in multicenter clinical trials or cooperative studies.
PHRM 576 / 476.
Molecular and Cellular Pharmacology.
(3)
An overview of principles and basis of modern molecular and cellular pharmacology.
{Spring}
PHRM 580.
General Toxicology.
(3)
An in-depth introduction to the basic principles and concepts of toxicology. Categories of chemicals causing toxic effects, the manner of exposure to toxic substances, the environmental and biological effects, and the laws and regulations will be considered.
PHRM 591.
Seminar in Administrative Pharmacy.
(1, no limit Δ)
This course will give the students experience in organizing and presenting their thoughts and interpretations on a selected subject. The seminar will provide the student with an opportunity to develop writing and formal oral presentation skills.
Restriction: permission of instructor.
PHRM 592.
Seminar in Radiopharmacy.
(1, no limit Δ)
Each masters candidate will be required to present a seminar on a topic of choice approved by his/her supervisor or selected by the supervisor.
Restriction: permission of instructor.
PHRM 593 / 493.
Pharmaceutical Sciences and Toxicology Seminar.
(1, no limit Δ)
Research seminars on current topics in pharmaceutical sciences and toxicology will be presented by students and faculty from within UNM and from invited speakers outside of UNM.
Restriction: permission of instructor.
PHRM 594.
Topics in Environmental Disease.
(1-3 to a maximum of 4 Δ)
Advanced readings in topics relating to toxicology and environmental disease, including areas such as chemical teratogenesis, reactive oxygen species, respiratory toxicology, receptor-medicated toxicology and environmentally induced cancer.
Prerequisite: 580.
Restriction: permission of instructor.
{Fall, Spring}
PHRM 597.
Research Problems in Pharmaceutical Sciences.
(1-6, no limit Δ)
Research in pharmaceutical sciences.
Restriction: permission of instructor.
PHRM 598.
Topics in Pharmaceutical Sciences.
(1-3 to a maximum of 4 Δ)
Advanced readings in topics relating to the pharmaceutical sciences in the areas of hospital pharmacy, pharmacy administration, radiopharmacy or toxicology.
Restriction: permission of instructor.
PHRM 599.
Master's Thesis.
(1-6, no limit Δ)
Offered on a CR/NC basis only.
PHRM 699.
Dissertation.
(1-9 to a maximum of 18 Δ)
Offered on a CR/NC basis only.
PHRM 710.
Mechanisms of Drug Action I.
(5)
First in a series of courses addressing principles of pharmacology, medicinal chemistry and biochemical mechanisms of drug action and toxicity. This section will specifically cover basics of drug metabolism and the pharmacology, structure-activity relationships (SAR), toxicology and elimination of drugs that act upon the autonomic nervous system.
PHRM 715.
Pathophysiology II.
(4)
PHRM 717.
Introductory Pharmacy Law.
(1)
An introduction to the Federal and New Mexico laws that relate to the practice of pharmacy.
PHRM 719.
Self-Care Therapeutics.
(2)
A pharmacotherapeutics course studying the use of non-prescription drugs, supplies, and herbal medicinals with emphasis on the pharmacist’s role as advisor, communicator, and educator to patients.
PHRM 720.
Introduction to Nuclear Pharmacy.
(2)
This course provides an overview of nuclear pharmacy as a practice specialty: contributions of the nuclear pharmacist and application of radioactive tracer techniques in the diagnosis and treatment of disease will be reviewed.
PHRM 721.
Self-Care Therapeutics II.
(1)
Self-Care involves the diagnosis, treatment, and prevention of one's own illness without professional expertise. This course will introduce the concept of pharmaceutical care by the use of life-style modification, over-the-counter medications, and natural remedies.
PHRM 732.
Mechanisms of Drug Action III.
(5)
Continuation of 710 and 731 addressing pharmacology, toxicology, SAR and elimination of prototypes in specific drug classes.
PHRM 735.
Substance Abuse Elective.
(2)
This course emphasizes the most important themes and concepts in the field. Lectures/presentations will cover major categories of drug abuse (Opioids, Marijuana, Stimulants, Hallucinogenics, CNS depressants, Performance-enhancing drugs, OTC drugs, Herbals, Plants, and Tobacco/Caffeine/EtOH).
PHRM 736 / 536.
Introduction to Pharmacogenomics.
(2)
An introduction to how inherited variations in genes dictate drug response. Topics covered include basic principles of medical genetics, chemotherapy improvement through pharmacogenomics, as well as the ethical, legal, and social impact of pharmacogenomics.
PHRM 737.
Introductory Spanish in the Pharmacy.
(1)
This course provides the pharmacy student with the basic tools to communicate with Spanish-speaking patients. Pharmacy-specific vocabulary and helpful structures will be covered in addition to fundamental grammar and conversational skills.
PHRM 738.
Intermediate Spanish in the Pharmacy.
(1)
A continuation of the introductory course. In addition to advancing the course participant's knowledge of basic medical terminology, the intermediate level introduces other relevant vocabulary topics for effective pharmacy communication in Spanish.
PHRM 739.
Pharmacotherapy I.
(6)
Introduces students to a systematic approach to patient-centered pharmaceutical care, emphasizing patient assessment, problem-solving, communication, and counseling skills. Begins pharmacotherapy sequence.
PHRM 740.
Self-Selected Supplementary Pharmacy Education.
(1-2 to a maximum of 2 Δ)
This course is designed to allow students to self-identify areas for supplemental pharmacy education. Student will select and complete ACPE-approved continuing education programs.
Offered on a CR/NC basis only.
PHRM 748.
Research Project (Initial).
(1)
Student formulates hypothesis for research project and establishes methodologies for completion under guidance of faculty. Research project approved by committee.
Offered on a CR/NC basis only.
PHRM 751.
Pharmacotherapy II.
(6)
Study of the therapy of common disease states by organ systems integrating the concepts from pathophysiology, pharmacology, biopharmaceutics, pharmacokinetics and pharmacoeconomics in the treatment of patients. Fully develops the concept of pharmaceutical care or how to provide the most cost-effective care of a patient including over-the-counter and natural remedies.
PHRM 755.
Seminar in Pharmacy.
(1, may be repeated once Δ)
Offered on a CR/NC basis only.
PHRM 756.
Safe Medication Practices.
(2)
A study of the existence of medication errors, reasons for these errors and suggested methods to prevent them from occurring.
PHRM 758.
Research Project.
(1, may be repeated four times Δ)
Student completes research project in final year. Up to four students may work collaboratively on one project.
Offered on a CR/NC basis only.
PHRM 759.
Advanced Law and Ethics.
(2)
Emphasis given to statues and regulations regulating the practice of pharmacy and distribution of drugs including the New Mexico Pharmacy Practice Act. Class discussion will include the application of ethics to situations in health care.
PHRM 762L.
Pharmaceutical Care Lab V.
(2)
Continuation of 733L, activities parallel concurrent pharmacotherapy courses. Emphasis on patient assessment, care planning, and monitoring.
PHRM 769.
Pharmacy Practice Experience.
(0-4, may be repeated four times Δ)
Rotations that allow students to participate in patient-centered care activities in different settings that are in-depth, structured, and carefully coordinated with other components of the curriculum and require active participation in patient care responsibilities.
PHRM 771.
Introductory Community Pharmacy Practice Experience.
(4)
A four-week (40 hours/week) directed dispensing pharmacy experience. Students will be exposed to ambulatory patient care in a community pharmacy setting.
Offered on a CR/NC basis only.
PHRM 772.
Introductory Institutional Pharmacy Practice Experience.
(3)
A four-week (40 hours/week) directed dispensing pharmacy experience. Students will be exposed to in-patient care in an institutional pharmacy setting.
Offered on a CR/NC basis only.
PHRM 773 [773 / 511].
Nuclear Pharmacy Instrumentation.
(3)
Structure and properties of atoms, radiation and radioactive decay, production of radionuclides, interactions of radiation with matter, with emphasis on instrumentation for radiation detection and measurement in a nuclear pharmacy or nuclear medicine environment.
Restriction: permission of instructor.
PHRM 774 [774 / 512].
Radiopharmaceutical Chemistry.
(1)
Introduces undergraduate students to inorganic chemistry as applicable to radiopharmaceuticals.
Prerequisite: CHEM **302.
Restriction: permission of instructor.
PHRM 775 [775 / 513].
Radiation Biology and Radiation Safety.
(3)
Fundamentals of the biological effects of ionizing radiation on living systems, especially man; basic biological mechanisms which bring about somatic and genetic effects. Concepts of radiation protection, radiation dosimetry, radiation monitoring and x-ray health physics.
Restriction: permission of instructor.
PHRM 776.
Radiopharmacology.
(3)
Study of the physicochemical characteristics of radiopharmaceuticals; kinetics of radiopharmaceuticals; structure-distribution relationships of radiopharmaceuticals; considerations in the design of new radiopharmaceuticals.
Restriction: permission of instructor.
PHRM 781.
Geriatric Medication Management - An Interprofessional Elective.
(2)
A course designed to provide hands-on experiences with geriatric patients in senior centers. Students will work with Nurse Practitioners and nursing students to evaluate blood pressures, blood glucoses, disease states and medication therapy.
PHRM 782.
Clinical Toxicology.
(2)
Study of the acute toxicity in humans of common drugs, chemicals and household products; physical and laboratory assessment of common poisonings; development of clinical management plans and role of pharmacists in prevention of poisonings. P3 standing in College of Pharmacy.
PHRM 784.
Advanced Infectious Diseases Pharmacotherapy.
(1)
This course will offer an in-depth discussion of the pharmacotherapy on several infectious diseases related topics such as advanced kinetics, MRSA treatment, liver diseases and infections, and HIV.
Prerequisite: 751 with a grade of "C" or better.
Restriction: permission of instructor.
PHRM 785.
Advanced Cardiovascular Pharmacotherapy.
(1)
This course is designed to give students an advanced knowledge and skill base in cardiovascular medicine and will include topics designed to allow the student to maximize the learning experience in the Cardiology APPE.
PHRM 786.
Geriatric Interprofessional Elective.
(2)
This course involves the study of the treatment of common geriatric disease states in multiple care settings and involves case-based discussion with an interprofessional team of students and instructors.
Offered on a CR/NC basis only.
PHRM 790.
Physical Assessment for the Pharmacist.
(2)
A physical assessment course to include instruction in performing physical assessment exams for all major organ systems, patient interviewing, and documentation for students who are interested in incorporating clinical pharmacy into their future practice.
PHRM 796.
Topics in Pharmacy Practice I.
(1-3 to a maximum of 9 Δ)
This course provides current and/or future pharmacy practice topics that are not otherwise provided within the required Doctor of Pharmacy course curriculum.
Offered on a CR/NC basis only.
Restriction: permission of instructor.
PHRM 797.
Topics in Pharmacy Practice II.
(1-3 to a maximum of 9 Δ)
This course provides current and/or future pharmacy practice topics that are not otherwise provided within the required Doctor of Pharmacy course curriculum.
Offered on a CR/NC basis only.
PHRM 798.
Problems in Pharmacy.
(1-5 to a maximum of 10 Δ)
Research and library problems in some phases of pharmacy.
Restriction: permission of instructor.
PHRM 801.
Applied Biochemistry.
(3)
The course covers basic principles of protein, carbohydrate and lipid function, metabolism, and an introduction to molecular mechanisms of drug action.
Restriction: admitted to Pharm.D. program.
PHRM 802.
Physical Pharmacy and Biopharmaceutics.
(3)
An introduction to physical pharmacy and biopharmaceutical principles impacting drug development and the performance of pharmaceutical dosage forms.
Restriction: admitted to Pharm.D. program.
PHRM 803.
Aspects of Patient Care I.
(3)
The first in a series of six courses, students are introduced to prescription processing and dispensing as well as patient communication. Drug information retrieval, Top 200 drugs, pharmaceutical calculation, and medical terminology are included.
Restriction: admitted to Pharm.D. program.
PHRM 804.
Public Health.
(2)
Presents New Mexico public health challenges in which pharmacists play a vital role in improving health of community and local population.
Restriction: admitted to Pharm.D. program.
PHRM 805.
Fundamentals of Pathophysiology and Immunology.
(3)
The fundamental basics of human pathophysiology and diagnostic tests used to evaluate normal and disease-based biomarkers and the underlying principles of immunology are presented as foundation for in-depth organ-specific disease states discussed in subsequent courses.
Restriction: admitted to Pharm.D. program.
PHRM 807.
Introduction to Pharmacy Practice and Communication.
(2)
This course will allow students to develop an understanding for the profession, insight into themselves as future health care professionals and enable students to learn the fundamentals of professional communication in healthcare settings.
Restriction: admitted to Pharm.D. program.
PHRM 809.
Pharmacy and Health Care Delivery Systems.
(2)
Explores the current U.S. healthcare delivery system models from perspective of pharmacy with emphasis on the influences of government policy, regulatory oversight and financial implications.
Restriction: admitted to Pharm.D. program.
PHRM 810.
Fundamentals of Pharmacokinetics and Dosage Forms.
(3)
An introduction to the influence of absorption, distribution, metabolism, and excretion on the time course of drug levels in body as well as fundamental principles in the design and manufacture of dosage forms.
Restriction: admitted to Pharm.D. program.
PHRM 811.
Introduction to Pharmacology and Medicinal Chemistry.
(4)
This course will specifically cover an introduction to pharmacology, basics of drug metabolism and the structure-activity relationships (SAR), toxicology and elimination of drugs that act upon the autonomic nervous system.
Restriction: admitted to Pharm.D. program.
PHRM 813.
Aspects of Patient Care II.
(2)
The second in a series of six courses, students continue dispensing and professional communication skills. Introduction to Pharmacists’ Patient Care Process with self-care products. Basic drug information, Top 200 drugs and non-sterile compounding.
Restriction: admitted to Pharm.D. program.
PHRM 815.
Integrated Pharmacotherapeutics and Self Care.
(4)
The introductory course to the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry, and pharmacotherapeutics pertaining to self-care and non-prescription pharmacotherapy.
Restriction: admitted to Pharm.D. program.
PHRM 817.
Introduction to Law, Ethics and Social Issues in Pharmacy.
(2)
Introduction to pharmacy law with considerations of professional ethics and social determinants of health that impact the professional practice of pharmacy.
Restriction: admitted to Pharm.D. program.
PHRM 819.
Professional Development I.
(1)
Series of seminars with focus on professionalism, leadership development, career exploration and decision-making, post graduate education opportunities, and contemporary professional practice issues influencing patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
PHRM 820.
Integrated Pharmacotherapeutics I.
(3)
The first course in the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry and pharmacotherapeutics as they relate to use in general ambulatory care for cardiology, endocrinology, and pulmonary disease states.
Restriction: admitted to Pharm.D. program.
PHRM 823.
Aspects of Patient Care III.
(2)
The third in a series of six courses, students focus on the Pharmacists’ Patient Care Plan involving prescription medications, patient history and more complex patient cases.
Restriction: admitted to Pharm.D. program.
PHRM 824.
Dosage Forms.
(3)
To provide students with an introduction to the fundamental principles of dosage forms, their design and the processes used in manufacturing and compounding drug products.
Restriction: admitted to Pharm.D. program.
PHRM 825.
Integrated Pharmacotherapeutics II.
(3)
The second course in the Integrated Pharmacotherapy sequence presents the pathophysiology, pharmacology, medicinal chemistry and pharmacotherapeutics as they relate to use in general ambulatory care for endocrinology, musculoskeletal pain and psychiatry.
Restriction: admitted to Pharm.D. program.
PHRM 828.
Pharmacoepidemiology and Research Design.
(2)
Introduction to basic concepts of pharmacoepidemiology and research study designs used to evaluate health, disease, and drug utilization. Methods of critical evaluation, analysis of biomedical literature, identification of reliable and valid research outcomes are presented.
Restriction: admitted to Pharm.D. program.
PHRM 829.
Professional Development II.
(1)
Series of seminars with focus on professionalism, leadership development, career exploration and decision-making, post graduate education opportunities, and contemporary professional practice issues influencing patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
PHRM 830.
Integrated Pharmacotherapeutics III.
(3)
The third course in the Integrated Pharmacotherapy sequence presents the pathophysiology, pharmacology, medicinal chemistry, and pharmacotherapeutics as they relate to antibiotic treatment of bacterial infections.
Restriction: admitted to Pharm.D. program.
PHRM 832.
Evidence-Based Clinical Decision Making.
(2)
This course develops skills to determine validity, applicability and significance of published clinical research for potential application in optimizing patient care.
Restriction: admitted to Pharm.D. program.
PHRM 833.
Aspects of Patient Care IV.
(2)
The fourth in a series of six courses, students focus on the Pharmacists’ Patient Care Plan involving prescription medications. Patient History and more complex patient cases.
Restriction: admitted to Pharm.D. program.
PHRM 835.
Integrated Pharmacotherapeutics IV.
(3)
The fourth course in the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry and pharmacotherapeutics as they relate to use in complex ambulatory care setting for a variety of disease states.
Restriction: admitted to Pharm.D. program.
PHRM 836.
Pharmacoeconomics.
(2)
The course covers fundamental concepts in pharmaceutical economic evaluations including decision model analysis. Provide a basic understanding of how to manage resources and optimize healthcare resource allocation with emphasis on drug treatments.
Restriction: admitted to Pharm.D. program.
PHRM 837.
Pharmacy Management and Operations.
(3)
Introduction to principles, skills, and practices relevant to successful business operation and management in a variety of pharmacy practice settings.
Restriction: admitted to Pharm.D. program.
PHRM 839.
Professional Development III.
(1)
Series of seminars with focus on professionalism, leadership development, career exploration and decision-making, post graduate education opportunities, and contemporary professional practice issues influencing patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
PHRM 840.
Integrated Pharmacotherapeutics V.
(2)
The fifth course in the Integrated Pharmacotherapy sequence presents the pathophysiology, pharmacology, medicinal chemistry, and pharmacotherapeutics as they relate to fungal and viral infections.
Restriction: admitted to Pharm.D. program.
PHRM 842.
Safe Medications and Pharmacy Informatics.
(3)
This course provides a study of the source/existence of medication errors, reasons for these errors and suggested methods (including pharmacy informatics) to prevent them from occurring.
Restriction: admitted to Pharm.D. program.
PHRM 843.
Aspects of Patient Care V.
(1)
The fifth in a series of six courses, students focus on the Pharmacists’ Patient Care Plan involving prescription medications. Patient History and more complex patient cases.
Restriction: admitted to Pharm.D. program.
PHRM 845.
Integrated Pharmacotherapeutics VI.
(4)
The sixth course in the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry, and pharmacotherapeutics as they relate to use in complex ambulatory care for neurological and psychiatric disease states.
Restriction: admitted to Pharm.D. program.
PHRM 847.
Integrated Pharmacotherapeutics VII.
(2)
The seventh course in the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry and pharmacotherapeutics as they relate to use in treatment and management of oncological disease states.
Restriction: admitted to Pharm.D. program.
PHRM 849.
Professional Development IV.
(1)
Series of seminars with focus on professionalism, leadership development, career exploration and decision-making, post graduate education opportunities, and contemporary professional practice issues influencing patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
PHRM 850.
Integrated Pharmacotherapeutics VIII.
(3)
The eighth course in the Integrated Pharmacotherapeutics sequence presents the pathophysiology, pharmacology, medicinal chemistry and pharmacotherapeutics as they relate to use in complex hospital care for cardiology, nutrition, critical care and clinical toxicology.
Restriction: admitted to Pharm.D. program.
PHRM 851.
Emerging Trends in Pharmacy.
(1)
A topics course intended to increase student awareness and understanding of contemporary issues related to pharmacy practice, pharmaceutical industry and health care.
Restriction: admitted to Pharm.D. program.
PHRM 853.
Aspects of Patient Care VI.
(1)
The sixth in a series of six courses, students focus on the Pharmacists' Patient Care Plan involving prescription medications. Patient History and more complex patient cases.
Restriction: admitted to Pharm.D. program.
PHRM 854.
Advanced Law and Ethics.
(2)
A review of state and federal statutes and regulations governing pharmacy within New Mexico. Compare and contrast current regulation with ethical decision making situations involving health care.
Restriction: admitted to Pharm.D. program.
PHRM 855.
Clinical Capstone.
(5)
Students will demonstrate professional ability to integrate and apply knowledge of basic sciences, pharmacotherapy, pharmacy practice management, oral/written communication, literature evaluation, drug information retrieval, and pharmacoeconomics in management of patients with multiple medical conditions.
Restriction: admitted to Pharm.D. program.
PHRM 859.
Professional Development V.
(1)
Series of seminars with focus on professionalism, leadership development, career exploration and decision-making, post graduate education opportunities, and contemporary professional practice issues influencing patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
PHRM 880.
Direct Patient Care Experience I.
(1)
Students participate in direct-patient care interactions with practitioners and patients advancing patient welfare in authentic practice settings. Participation in Pharmacist Patient Care Process emphasizes patient data collection and assessment for possible medication-related problems.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
PHRM 881.
Direct Patient Care Experience II.
(1)
Students participate in direct-patient care interactions with practitioners and patients to advance patient welfare in authentic practice settings. Pharmacist Patient Care Process emphasizes medication distribution systems and high quality, interprofessional, and team-based patient care.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
PHRM 889.
Advanced Pharmacy Practice Seminar.
(1, may be repeated once Δ)
A hybrid seminar course addressing current updates and trends of best practices in pharmacy practice.
Offered on a CR/NC basis only.
Restriction: admitted to Pharm.D. program.
PHRM 890.
Advanced Community Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy experience in an outpatient, community setting. By observing and practicing, students develop skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
PHRM 891.
Advanced Institutional Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy experience in an inpatient or institutional setting. By observing and practicing, students will develop skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
PHRM 893.
Ambulatory Care Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy experience in an outpatient setting. By observing and practicing, students will develop their skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
PHRM 894.
General and Adult Medicine Advanced Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy experience in an adult medicine setting. By observing and practicing, students will develop their skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
PHRM 895.
Direct Patient Care Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy practice experience in an outpatient and/or inpatient setting. By observing and practicing, students will develop skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
PHRM 896.
Indirect Patient Care Pharmacy Practice Experience.
(4, may be repeated three times Δ)
This course is a supervised pharmacy experience involving no direct patient care. By observing and practicing, students will develop their skills to be practice- and team-ready.
Restriction: admitted to Pharm.D. program.
